Dipeptidyl Peptidase-4 Inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dipeptidyl Peptidase-4 Inhibitor, covering 2021-03-23 to 2021-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 [Phase 3]